Wolverine Trading
MRNS

Wolverine Trading’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Wolverine Trading’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,800
Closed -$23.6K – 6014
2024
Q3 		$23.6K Buy
+12,800
New +$17.9K ﹤0.01% 4618
2024
Q2 		– Sell
-16,700
Closed -$151K – 5397
2024
Q1 		$151K Sell
16,700
-6,900
-29% -$67.1K ﹤0.01% 3915
2023
Q4 		$257K Sell
23,600
-24,400
-51% -$183K ﹤0.01% 3614
2023
Q3 		$386K Buy
+48,000
New +$399K ﹤0.01% 3029
2023
Q2 		– Sell
-17,100
Closed -$120K – 5154
2023
Q1 		$120K Buy
+17,100
New +$107K ﹤0.01% 3618
2021
Q4 		– Sell
-20,700
Closed -$236K – 7096
2021
Q3 		$236K Buy
20,700
+5,800
+39% +$79.8K ﹤0.01% 5089
2021
Q2 		$270K Buy
14,900
+2,400
+19% +$38.6K ﹤0.01% 4569
2021
Q1 		$179K Sell
12,500
-23,100
-65% -$334K ﹤0.01% 5134
2020
Q4 		$439K Sell
35,600
-4,000
-10% -$55.8K ﹤0.01% 3314
2020
Q3 		$460K Buy
39,600
+36,275
+1,091% +$313K ﹤0.01% 2914
2020
Q2 		$33K Sell
3,325
-4,150
-56% -$38.2K ﹤0.01% 4379
2020
Q1 		$55K Sell
7,475
-2,825
-27% -$24.5K ﹤0.01% 4227
2019
Q4 		$89K Sell
10,300
-3,675
-26% -$20.6K ﹤0.01% 4318
2019
Q3 		$85K Sell
13,975
-2,450
-15% -$19.8K ﹤0.01% 3905
2019
Q2 		$273K Buy
16,425
+1,850
+13% +$32.1K ﹤0.01% 3378
2019
Q1 		$244K Buy
14,575
+8,525
+141% +$123K ﹤0.01% 3598
2018
Q4 		$73K Buy
+6,050
New +$122K ﹤0.01% 4079

Other funds holding MRNS

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wolverine Trading's MRNS Position: Q2 2024 in Review

Wolverine Trading sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2024, closing a stake of 11,165 shares — an estimated $101K sold.

Wolverine Trading first reported a position in MRNS in Q4 2018 and held it in 11 quarters. The position peaked at $261K in Q1 2021. 90 funds tracked by Wall St. Rank hold MRNS as of Q2 2024.

  • Wolverine Trading reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2024 after selling out during the quarter.
  • Wolverine Trading sold 11,165 Marinus Pharmaceuticals, Inc shares in Q2 2024, an estimated $101K.
  • Wolverine Trading first reported a position in Marinus Pharmaceuticals, Inc in Q4 2018 and held it in 11 quarters.
  • Wolverine Trading's Marinus Pharmaceuticals, Inc position peaked at $261K in Q1 2021.
  • 90 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2024.

Based on Wolverine Trading's 13F filing for Q2 2024, filed 14 Aug 2024.